Last Posted: Jan 17, 2018
- For Now, Sequencing Cancer Tumors Holds More Promise Than Proof
NPR Morning Edition, Jan 15, 2018 - Interactive or static reports to guide clinical interpretation of cancer genomics.
Gray Stacy W et al. Journal of the American Medical Informatics Association : JAMIA 2018 Jan - The emerging significance of secondary germline testing in cancer genomics.
Mandelker Diana et al. The Journal of pathology 2018 Jan - Genetic Variations in the 3'-untranslated Regions of Genes Involved in the Cell Cycle and Apoptosis Pathways Affect Bladder Cancer Risk.
Zhang Qiang, et al. Cancer genomics & proteomics 0 0 (1) 67-72 - Cancer Drugs Approved Based on Biomarkers and Not Tumor Type—FDA Approval of Pembrolizumab for Mismatch Repair-Deficient Solid Cancers
V Prasad et al, JAMA Oncology, Dec 27, 2017 - https://www.cancer.gov/news-events/cancer-currents-blog/2017/genomic-profiling-tests-cancer
NCI, Dec 21, 2017
No hay comentarios:
Publicar un comentario